Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 7 (NPM1P7)
- Target
- NPM1P7
- Molecular classification
- Other (pseudogene), Not classified as receptor, enzyme, transporter, or transcription factor
01
Overview
Nucleophosmin 1 pseudogene 7 (NPM1P7, also known as NG7-6) is classified as a pseudogene related to the nucleophosmin family. Unlike its parental gene, NPM1, which encodes a nucleolar phosphoprotein involved in ribosome biogenesis, cell cycle regulation, and genomic stability[1][3][5], NPM1P7 does not encode a functional protein and has no described biological or disease-related functions[2]. It is listed only as a genomic locus and does not contribute to molecular signaling, therapeutic drug targeting, or biological processes. There is no evidence to suggest NPM1P7 is involved in pathology, pharmacology, or used as a biomarker.
- Other names
- NPM1P7NG7-6NPMP7
02
Mechanism of action
None; no mechanisms of drug action are described for pseudogenes like NPM1P7.
03
Biological functions
None known; as a pseudogene, NPM1P7 is not recognized to produce a functional protein or to have a direct role in biological processes[2].
04
Disease associations
None known; there are no documented disease associations or roles for NPM1P7.
05
Safety considerations
None specific; there are no safety or therapeutic concerns described for pseudogenes like NPM1P7.
06
Interacting drugs
None; there are no known drugs that interact with NPM1P7, as it is not an active protein or molecular target.
07
Biomarkers
None; NPM1P7 is not used as a biomarker for patient selection or efficacy monitoring.
Beyond the preview
Go deeper on Nucleophosmin 1 pseudogene 7 (NPM1P7).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 7 (NPM1P7).